Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Edgemont Pharmaceuticals has launched a new formulation dose of bupropion extended-release tablets in a strength of 450mg dose.
Subscribe to our email newsletter
The Forfivo XL, which the company claims, is the only available 450mg dose of an extended-release bupropion product and is intended for the treatment of major depressive disorder (MDD).
Edgemont Pharmaceuticals president and CEO Douglas Saltel said until now, most patients in the US requiring a 450mg dose of bupropion have been taking multiple tablets to achieve their dose requirement.
"We are very pleased to be able to simplify the dosing regimen for these patients to a single Forfivo XL 450mg tablet once-daily," Saltel added.
The company said Bupropion Hcl is marketed under several dosage forms and brand names including Wellbutrin, Wellbutrin SR and Wellbutrin XL.